The Latest Breaking News from Fibromyalgia

Former Desert Island Discs presenter Kirsty Young departed as host of the show in 2018 because of her fibromyalgia and rheumatoid arthritis and has since returned

BBC presenter appeared in a special Christmas Day episode of ‘Desert Island Discs’ with Lauren Laverne, where she spoke about her struggles with fibromyalgia and rheumatoid arthritis

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

Julie Inglis, 53, was forced to retire after multiple strokes, and now lives with several conditions, including fibromyalgia.

Jacquie Dean relies heavily on her mobility equipment due to her arthritic knees and fibromyalgia, but due to the rising living costs she can no longer afford to power her scooter

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares climbed 34.6% to $4.1993 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

NeuroMetrix Inc (NASDAQ: NURO) shares are trading higher by 30.10% at $4.06 after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation device as an aid for reducing the symptoms of fibromyalgia.

By David Bautz, PhD NASDAQ:VIRI READ THE FULL VIRI RESEARCH REPORT